Navigation Links
NIST and partners identify tiny gold clusters as top-notch catalysts
Date:9/5/2008

For most of us, gold is only valuable if we possess it in large-sized pieces. However, the "bigger is better" rule isn't the case for those interested in exploiting gold's exceptional ability to catalyze a wide variety of chemical reactions, including the oxidation of poisonous carbon monoxide (CO) into harmless carbon dioxide at room temperatures. That process, if industrialized, could potentially improve the effectiveness of catalytic converters that clean automobile exhaust and breathing devices that protect miners and firefighters. For this purpose, nanoclustersgold atoms bound together in crystals smaller than a strand of DNAare the size most treasured.

Using a pair of scanning transmission electron microscopy (STEM) instruments for which spherical aberration (a system fault yielding blurry images) is corrected, researchers at the National Institute of Standards and Technology (NIST), Lehigh University (Bethlehem, Pa.) and Cardiff University (Cardiff, Wales, United Kingdom) for the first time achieved state-of-the-art resolution of the active gold nanocrystals absorbed onto iron oxide surfaces. In fact, the resolution was sensitive enough to even visualize individual gold atoms.

The work is reported in the Sept. 5, 2008, issue of Science.

Surface science studies have suggested that there is a critical size range at which gold nanocrystals supported by iron oxide become highly active as catalysts for CO oxidation. However, the theory is based on research using idealized catalyst models made of gold absorbed on titanium oxide. The NIST/Lehigh/Cardiff aberration-corrected STEM imaging technique allows the researchers to study the real iron oxide catalyst systems as synthesized, identify all of the gold structures present in each sample, and then characterize which cluster sizes are most active in CO conversion.

The research team discovered that size matters a lotsamples ranged from those with little or no catalytic activity (less than 1 percent CO conversion) to others with nearly 100 percent efficiency. Their results revealed that the most active gold nanoclusters for CO conversion are bilayers approximately 0.5-0.8 nanometer in diameter (40 times smaller than the common cold virus) and containing about 10 gold atoms. This finding is consistent with the previous surface science studies done on the gold-titanium oxide models.


'/>"/>

Contact: Michael E. Newman
michael.newman@nist.gov
301-975-3025
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Related biology technology :

1. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
2. PAREXEL International To Present at Thomas Weisel Partners Healthcare Conference
3. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
4. Gen-Probe to Webcast Presentation at the Thomas Weisel Partners Healthcare Conference 2008
5. Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
8. Oridion Expands its OEM Partnerships - New Agreement with Spacelabs Healthcare
9. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
10. Catalyst Pharmaceutical Partners Reports Second Quarter 2008 Financial Results
11. Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIST and partners identify tiny gold clusters as top-notch catalysts
(Date:12/8/2016)... 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix or ... and commercializing products to treat rare diseases where there ... will be hosting an Investor Webcast Event Friday, December ... of innate defense regulators (IDRs) as a new drug ... and the recently announced and published Phase 2 clinical ...
(Date:12/8/2016)...   Biocept, Inc . (NASDAQ: ... actionable liquid biopsy tests to improve the management ... its Target Selectorâ„¢ Circulating Tumor Cell platform demonstrated ... of actionable biomarkers in patients with metastatic breast ... Cannon Research Institute (SCRI), the research arm of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical ... immunotherapeutic products for the treatment of cancer, today ... Manufacturing Development Program with Cytovance Biologics ( ... oregovomab antibody product. Supported by recent positive interim ... in ovarian cancer patients, OncoQuest has engaged Cytovance ...
(Date:12/7/2016)... ROCHESTER, Minn. , Dec. 7, 2016  Vyriad ... McQuinn to the company,s Board of Directors. ... board as we build our business and develop our ... for cancer therapy," said Stephen Russell , MD, ... Mary Agnes , share our vision and passion for ...
Breaking Biology Technology:
(Date:11/15/2016)... 2016 Research and Markets has announced the ... report to their offering. ... The ... 2021 from USD 6.21 Billion in 2016, growing at a CAGR ... the bioinformatics market is driven by the growing demand for nucleic ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/20/2016)... , June 20, 2016 Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... prisons involved, it has secured the final acceptance ... facilities for Managed Access Systems (MAS) installed. Furthermore, ... facilities to be installed by October, 2016. MAS ...
Breaking Biology News(10 mins):